ARTICLE | Company News
Pharmexa licenses production system from GSK
June 14, 2001 7:00 AM UTC
Pharmexa (CSE:PHARMX) in-licensed from GlaxoSmithKline (GSK; LSE:GSK) a vector cell production system for use in its AutoVac HER-2 protein project against cancer. ...